Article
Biomarkers and prognostic stratification in psoriatic arthritis.
Reumatismo - 5 Jun 2012
Bogliolo L, Crepaldi G, Caporali R
Abstract excerpt
In rheumatic diseases, biomarkers may serve as surrogate endpoints for diagnosis, prognosis, disease activity, therapeutic response and disease outcome. In recent years a great effort has been made to identify useful tools to establish early diagnosis, prognosis and therapeutic response especially in rheumatoid arthritis (RA). In psoriatic arthritis (PsA) serological biomarkers have been frequently borrowed from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
